Patents for C07K 19 - Hybrid peptides (29,428) |
---|
04/09/1997 | EP0766566A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
04/08/1997 | US5618536 Chimeric papillomavirus-like particles |
04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
04/03/1997 | WO1997012043A2 Hcv ns3 protein fragments having helicase activity and improved solubility |
04/03/1997 | WO1997011713A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
04/03/1997 | CA2230933A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
04/02/1997 | EP0765936A1 Cloning of mite allergens |
04/02/1997 | EP0654085B1 Monomeric and dimeric antibody-fragment fusion proteins |
04/02/1997 | EP0528856B1 Processes and intermediates for synthetic antibody derivatives |
04/02/1997 | EP0436597B1 Generation and selection of recombinant varied binding proteins |
04/02/1997 | CN1146772A Synthetic peptide based immunogens for the treatment of allergy |
04/01/1997 | US5616482 Protein fragments including an enzyme fragment a of diphtheria toxin bound together and also bound to a polypeptide ligand able to bind to selected cells; antitumor and carcinogenic agents |
03/27/1997 | WO1997011187A1 Subtilisin inhibitor of streptomyces venezuelae, and use of the gene sequences for expression and/or secretion of heterologous proteins in streptomyces |
03/27/1997 | WO1997011094A1 Novel variants of green fluorescent protein, gfp |
03/27/1997 | WO1997001636A3 Recombinant mistletoe lectin |
03/26/1997 | CN1146136A Targeted cytolysis of HIV-infected cells by Chimeric CD4 receptor bearing cells |
03/25/1997 | US5614191 Antitumor |
03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
03/25/1997 | CA1339027C Synthetic peptides, antibodies directed against them, and the use thereof |
03/25/1997 | CA1339013C Cross-protective human monoclonal antibody compositions |
03/20/1997 | WO1997010253A1 A high throughput assay using fusion proteins |
03/20/1997 | CA2231330A1 A high throughput assay using fusion proteins |
03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
03/19/1997 | EP0762895A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
03/19/1997 | EP0762892A1 Diphtheria toxin vaccines bearing a mutated r domain |
03/19/1997 | CN1145589A Method for antigen-specific immunoregulation by T-Cell alpha chain |
03/19/1997 | CN1145369A Peptide useful as ligand |
03/18/1997 | CA2050302C Polypeptide having immunological activity for use as diagnostic reagent |
03/13/1997 | WO1997009429A2 Compounds and methods for diagnosis of tuberculosis |
03/13/1997 | WO1997009427A1 Vegf-related protein |
03/13/1997 | WO1997009418A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
03/13/1997 | WO1997009347A1 Cytolytic bradykinin antagonists |
03/13/1997 | CA2684425A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
03/13/1997 | CA2653566A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
03/13/1997 | CA2231400A1 Vegf-related protein |
03/13/1997 | CA2230927A1 Compounds and methods for diagnosis of tuberculosis |
03/13/1997 | CA2230907A1 Cytolytic bradykinin antagonists |
03/13/1997 | CA2230858A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) |
03/12/1997 | EP0760858A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
03/12/1997 | EP0367767B1 Bacillus thuringiensis p-2 toxin gene, protein and related insecticide compositions |
03/11/1997 | US5610280 Antitumor |
03/11/1997 | US5610137 Transgenic, cross-linked hemoglobin |
03/11/1997 | US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods |
03/11/1997 | US5610009 Mammalian expression systems for hepatitis C virus envelope genes |
03/11/1997 | US5609870 Antisecretory, immunology |
03/06/1997 | WO1997008550A1 Retinoid x receptors and components of the basal transcription machinery |
03/06/1997 | WO1997008311A1 Novel procollagens |
03/06/1997 | WO1997008198A1 Antigenic peptide compounds and immunoassay method |
03/06/1997 | WO1997008196A1 Neurturin and related growth factors |
03/06/1997 | WO1997008195A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
03/06/1997 | WO1997007769A2 Chemical compounds |
03/06/1997 | CA2230689A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
03/06/1997 | CA2230637A1 Retinoid x receptors and components of the basal transcription machinery |
03/06/1997 | CA2227040A1 Chemical compounds |
03/05/1997 | EP0759995A1 Fusion glycoprotein from hcmv and hsv |
03/05/1997 | EP0759944A1 Improvements in or relating to peptide delivery |
03/05/1997 | EP0759930A1 Chimeric mhc class i antigens for inducing allograft tolerance |
03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
03/04/1997 | US5608151 Anti-microbial proteins |
03/04/1997 | US5608039 Single chain B3 antibody fusion proteins and their uses |
03/04/1997 | US5607919 Anti-microbial proteins |
03/04/1997 | US5607862 Assay for N-terminal type I collagen telopeptide that survives bone resorption in vivo |
03/04/1997 | US5607676 Immunogenic compositions against gastrin peptides |
02/27/1997 | WO1997007218A1 Allergen-xcd32 fusion proteins |
02/27/1997 | WO1997007132A1 Epitope tagging system |
02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
02/27/1997 | WO1996040885A3 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
02/27/1997 | CA2229540A1 Epitope tagging system |
02/27/1997 | CA2227795A1 Allergen-xcd32 fusion proteins |
02/26/1997 | EP0759466A2 Low binding affinity interleukin-12 beta receptors |
02/26/1997 | EP0759081A1 Glucan-binding proteins, and use thereof |
02/26/1997 | EP0759037A1 Antigen/antibody specificity exchanger |
02/25/1997 | US5606043 Methods for the diagnosis of glaucoma |
02/25/1997 | US5606030 Coconjugates of OMPC, HIV related peptides and anionic moieties |
02/25/1997 | US5606017 Antitumor agents |
02/25/1997 | US5605821 Expression control sequences of the P-selectin gene |
02/25/1997 | US5605803 Human sperm diagnostic |
02/25/1997 | US5605692 Polypeptide |
02/20/1997 | WO1997005886A1 Compositions for conferring immunogenicity to a peptide |
02/19/1997 | EP0758394A1 Bifunctional protein, preparation and use |
02/19/1997 | EP0758393A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils |
02/19/1997 | EP0758383A1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
02/19/1997 | CN1142973A Vaccine composition having antitumour activity and use thereof in therapy of malignant diseases |
02/18/1997 | US5604115 Liver enriched transcription factor |
02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
02/13/1997 | WO1996013583A3 Targeted hetero-association of recombinant proteins to multi-functional complexes |
02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
02/12/1997 | EP0757720A1 Trimerising polypeptides, their manufacture and use |
02/12/1997 | EP0757696A1 Human sperm diagnostic |
02/12/1997 | EP0470184B1 Antibodies specific for cd4-binding domain of hiv |
02/11/1997 | US5602095 Recombinant pseudomonas exotoxin with increased activity |
02/11/1997 | US5602031 DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them |
02/11/1997 | US5602009 Expressing in recombinant host cell transfected dna encoding trans-repressing chimeric receptors comprising dna-binding domain linked to specified sequence of v-erba protein |